Baylor Scott & White Health

What it reported doing in 2024

See Schedule OEstablished in 1984, Baylor Scott & White Research Institute (BSWRI) is responsible for the oversight and management of all translational, observational, and clinical research conducted throughout the Baylor Scott & White Health (BSWH) system.BSWRI expanded its operations in 2013 as part of the merger between Dallas-based Baylor Health Care System and Temple-based Scott & White Healthcare, which created BSWH the largest nonprofit health system in Texas. Today, BSWH has over 1,300 patient access points including 53 hospitals, 600+ specialty care clinics, 250+ outpatient clinics, 150+ primary care clinics, 29 pharmacies, 30+ ambulatory surgery centers, 60+ urgent care clinics, and over 7,300 active physicians. The system also includes a state certified health maintenance organization, the Scott and White Health Plan and the Baylor Scott & White Quality Alliance accountable care organization both covering approximately 1,200,000 lives.BSWRI brings innovation to the forefront of medicine. From contributing to discoveries that help create new treatment options, to studying population health and other trends that improve quality of care, we pursue research focused on bringing patients greater value and addressing the health needs of the communities we serve. We are dedicated to advancing healthcare and ultimately, patient care, through the study and discovery of new preventive therapies and treatments for a broad spectrum of diseases and other chronic conditions. This means our efforts extend beyond microscopic studies; they bring innovation to the patient's bedside. We focus on understanding the base of a disease or condition, in order to then identify potential treatments or preventive therapies and enroll patients in research trials to further test and/or validate each theory. BSWRI is accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), which is a voluntary, peer-driven, and education-based model of accreditation.BSWRI is home to a rich network of over 600 team members operating within two administrative offices, four clinical trials offices, and directly within various BSWH centers, hospitals and clinics. Research staff include principal investigators, contracts and finance specialists, compliance and regulatory specialists, research coordinators, nurses, managers, data analysts and lab assistants, among others. The group oversees research activities supporting over 1,200studies in more than 50 specialty areas annually, including infectious disease, cardiology, gastroenterology, trauma, rehabilitation, neurology, oncology and radiation, orthopedics, pathology, radiology, transplant and surgery. Research conducted by and supported by our organization is regularly published in major scientific journals and reported at medical and scientific meetings. This work has also resulted in more than 1,600 issued and pending patents and trademark registrations spanning immunotherapy, genomics, biomarkers, metabolomics, metabolics, cardiovascular disease and medical devices. The following is a brief snapshot of activities led through BSWRI: Cardiovascular research: BSWRI holds a robust cardiovascular portfolio with study enrollment activities spanning multiple BSWH sites. Each year, we enroll and monitor hundreds of patients as part of major clinical trials examining therapeutic and surgical approaches and outcomes, new medications and new devices. Our cardiovascular research portfolio supports trials spanning: Atrial Fibrillation, Vascular/TAA conditions, Heart Failure Transplant, Heart Rhythm Disorders, Hypercholesterolemia, Aortic Valve Disorders, Cardiorenal Syndrome, Electrophysiology, Coronary Artery Disease, & Mitral Valve Disorders.Oncology research: The newest research hub within BSWRI is the Texas Cancer Interception Institute (TCII), created to attract and conduct innovative oncology clinical trials and research projects to help advance the science. Through advanced dia

Financial Efficiency

• Mission deployment rate: 84.7%; rating input score 85
• Program expense ratio: 88%; rating input score 88
• Fundraising efficiency: Limited

Transparency & Controls

• Consistency checks: 100%; rating input score 100; 68th percentile among comparable filings
• Pay-setting controls: 4 of 6 controls in place; rating input score 67
  • Compensation committee: Pass
  • Independent consultant: Pass
  • Other Form 990s reviewed: Missing
  • Written employment contract: Missing
  • Compensation survey or study: Pass
  • Board or committee approval: Pass
• Foreign activity oversight: Scored; rating input score 0
• Grant itemization coverage: Scored; rating input score 0
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: Yes; rating input score 100

Accountability

• Independent voting board: 0%; rating input score 0; 4th percentile among comparable filings
• Governance controls: 9 of 9 controls in place; rating input score 100
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: Pass
  • Other executive compensation review process: Pass
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Pass
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: 4%; rating input score 52; 52nd percentile among comparable filings
• Total-asset coverage ratio: 2.23; rating input score 67; 67th percentile among comparable filings
• Liabilities to assets ratio: 0.1; rating input score 83; 83rd percentile among comparable filings
• Officer compensation ratio: 4.2%; rating input score 23; 23rd percentile among comparable filings

Growth

• Program expense growth: 3.3% per year; rating input score 100; 24th percentile among comparable filings
• Revenue growth: 3.3% per year; rating input score 100; 25th percentile among comparable filings
• Asset growth: 2.6% per year; rating input score 100; 18th percentile among comparable filings